glucocorticoids

Systematic analysis of COVID-19 infection and symptoms in a systemic lupus erythematosus population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments
Zoé Gendebien, Christian von Frenckell, Clio Ribbens, Béatrice André, Marie Thys, Marjorie Gangolf, Laurence Seidel, Michel G Malaise, Olivier Malaise

Annals of the Rheumatic Diseases Jun 2021, 80 (6) e94; DOI: 10.1136/annrheumdis-2020-218244
Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis
Andrea Hermina Györfi, Markus Kopp, Matthias May, Marcel Vetter, Michael Uder, Andreas E Kremer, Georg Schett, Thomas Harrer, Jörg H W Distler

Annals of the Rheumatic Diseases Jun 2021, 80 (6) e87; DOI: 10.1136/annrheumdis-2020-218258
Increased rather than decreased incidence of giant-cell arteritis during the COVID-19 pandemic
Augustin Lecler, Delphine Villeneuve, Catherine Vignal, Thomas Sené

Annals of the Rheumatic Diseases Jun 2021, 80 (6) e89; DOI: 10.1136/annrheumdis-2020-218343
Antibody response to SARS-CoV-2 in patients receiving glucocorticoids with or without tocilizumab for COVID-19-associated hyperinflammation
Marlou T H F Janssen, Sofia Ramiro, Robert B M Landewé, César Magro-Checa, Rémy L M Mostard

Annals of the Rheumatic Diseases May 2021, annrheumdis-2021-220040; DOI: 10.1136/annrheumdis-2021-220040
Impact of COVID-19 pandemic on patients with SLE: results of a large multicentric survey from India
Mohit Goyal, Pravin Patil, Himanshu Pathak, Sham Santhanam, Anshul Goel, Vishnu Sharma, Akshat Pandey, Nikhil Gupta, Rahul Jain, Shashank Akerkar, Parthajit Das, Rajkiran Dudam, Naval Mendiratta, Bimlesh Dhar Pandey, Mithun CB, Bharat K Singh, Sharath Kumar, Nilesh Nolkha, Shriyanka Jain, Somya Jain, Ashish Sharma, Durga Prasanna Misra

Annals of the Rheumatic Diseases May 2021, 80 (5) e71; DOI: 10.1136/annrheumdis-2020-218013
Dynamical trajectory of glucocorticoids tapering and discontinuation in patients with rheumatoid arthritis commencing glucocorticoids with csDMARDs: a real-world data from 2009 to 2020
Wenhui Xie, Hong Huang, Guangtao Li, Yanjie Hao, Yanni Gui, Yu Wang, Xuerong Deng, Juan Zhao, Yan Geng, LanLan Ji, Xiaohui Zhang, Zhibo Song, Zhuoli Zhang

Annals of the Rheumatic Diseases Apr 2021, annrheumdis-2021-220112; DOI: 10.1136/annrheumdis-2021-220112
Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial
Veerle Stouten, René Westhovens, Sofia Pazmino, Diederik De Cock, Kristien Van der Elst, Johan Joly, Delphine Bertrand, Patrick Verschueren

Annals of the Rheumatic Diseases Apr 2021, annrheumdis-2020-219825; DOI: 10.1136/annrheumdis-2020-219825
Rheumatoid arthritis, bone and drugs: a dangerous interweave
Salvatore Minisola, Jessica Pepe, Cristiana Cipriani

Annals of the Rheumatic Diseases Apr 2021, 80 (4) 409-410; DOI: 10.1136/annrheumdis-2020-219545
Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study
Shahab Abtahi, Johanna H M Driessen, Andrea M Burden, Patrick C Souverein, Joop P van den Bergh, Tjeerd P van Staa, Annelies Boonen, Frank de Vries

Annals of the Rheumatic Diseases Apr 2021, 80 (4) 423-431; DOI: 10.1136/annrheumdis-2020-218758
Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients
FAI2R /SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors

Annals of the Rheumatic Diseases Apr 2021, 80 (4) 527-538; DOI: 10.1136/annrheumdis-2020-218310

Main menu

glucocorticoids

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

glucocorticoids

Pages